Ainos, Inc. (Nasdaq: AIMD) develops novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine. The company’s products include VELDONA clinical-stage human therapeutics, VELDONA Pet Cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.